Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020–present)

Xiaoyu Shi(Shandong University), Peng Zhan(Union Hospital), Edeildo Ferreira da Silva‐Júnior(Universidade Federal de Alagoas), Jian Zhang(Shanxi Medical University), Shujing Xu(Shandong University), Xinyong Liu(Shandong University of Traditional Chinese Medicine), Tong Zhao(China Pharmaceutical University), Shenghua Gao
Expert Opinion on Therapeutic Patents
December 2, 2022
10.1080/13543776.2022.2165911
Cited by 35

Related Papers

Identification of a cellularly active SIRT6 allosteric activator
|Nature Chemical Biology|2018|272
Structural basis for activity regulation of MLL family methyltransferases
|Nature|2016|253
Overview of Recent Strategic Advances in Medicinal Chemistry
|Journal of Medicinal Chemistry|2019|181
Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells
|Cell Death and Disease|2015|94
Identification of Dihydrofuro[3,4-<i>d</i>]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties
|Journal of Medicinal Chemistry|2019|87